At Ibn Khaldoun Medical Center, innovation is not simply a word; it is a commitment to our patients. In our constant effort to improve the quality of life of people facing cancer, we have placed Photobiomodulation (PBM) at the heart of our supportive care approach. This page retraces the dedicated and visionary history of our center in the development of this cutting-edge technology in Tunisia, establishing us as a recognized leader in this field.
2022: The Founding Step – A Scientific Vision
Our commitment to photobiomodulation dedicated to oncology began in a structured and ambitious way in 2022.
- Launch of an Open Scientific Day: This year marked a turning point with the organization of the first Scientific Day dedicated to Photobiomodulation in Oncology, as part of our annual congress on oncology and radiotherapy. This landmark event brought together national and international experts to discuss scientific evidence, protocols and the potential of PBM in managing the side effects of anticancer treatments, including mucositis, radiation dermatitis and lymphedema.
- A Clear Ambition: From the outset, our objective was to lay strong foundations for the successful integration of this therapy within our institution, based on science and best clinical practices.
2023 – 2024: Consolidation Through Research and Training
The following years were devoted to deepening our expertise and demonstrating the concrete benefits of PBM.
- Continuation of Annual Scientific Days: Each edition of our annual congress made it possible to broaden the discussion, train our healthcare professionals and raise awareness within the Tunisian medical community about advances in this field.
- Active Clinical Research: Our multidisciplinary teams, including oncologists, radiation oncologists and researchers, conducted studies and collected clinical data on the effectiveness of PBM in our patients. This work helped refine our protocols and confirm its significant impact on pain reduction and quality-of-life improvement.
May 2025: Creation of the First Photobiomodulation Unit in Tunisia
The Fulfillment of a Vision
Building on its experience and results, Ibn Khaldoun Medical Center reached a historic milestone in May 2025.
- A National and Continental First: We officially inaugurated the first unit entirely dedicated to Photobiomodulation in Oncology in Tunisia and in Africa. This major milestone reflects our leadership and our determination to offer patients exceptional quality care.
- An Integrated and Modern Unit: This unit is equipped with the latest technologies and managed by a specialized team trained in the most effective protocols. It is fully integrated into the oncology care pathway, providing proactive and personalized management of treatment-related side effects.
Our Vision for the Future
The creation of this unit is not an end in itself, but the beginning of a new chapter. Ibn Khaldoun Medical Center is committed to continuing:
- Clinical innovation by exploring new applications of PBM.
- Scientific research to contribute to global knowledge in this field.
- Training of healthcare professionals in Tunisia and across Africa.
- Continuous improvement in the quality of life of our patients.
Conclusion
The history of photobiomodulation at Ibn Khaldoun Medical Center reflects our philosophy: combining clinical excellence with a forward-looking vision. From the first scientific day in 2022 to the inauguration of our dedicated unit in 2025, every step has been taken with the same determination: to offer our patients the most innovative and most humane treatments. At Ibn Khaldoun Medical Center, the future of supportive oncology care is already here.
